COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT IN TREATING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN SWEDEN

被引：0
|
作者：
Clements, K. M. [1 ]
Hulbert, E. M. [2 ]
Panchmatia, H. R. [1 ]
Eriksson, M. [3 ]
Wittrup-Jensen, K. U. [4 ]
Nilsson, J. [5 ]
Weinstein, M. C. [6 ]
机构：
[1] OptumInsight, Cambridge, MA USA
[2] OptumInsight, Eden Prairie, MN USA
[3] Bayer AB, Solna, Sweden
[4] Bayer Pharma AG, Berlin, Germany
[5] OptumInsight, Stockholm, Sweden
[6] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1168
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A506 / A506
页数：1
相关论文
共 50 条
  • [41] Lamellar macular hole following intravitreal aflibercept injection in a patient with neovascular age-related macular degeneration
    Bagci, Fatma
    Citirik, Mehmet
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 728 - 732
  • [42] Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
    Yasuo Yanagi
    Kanji Takahashi
    Tomohiro Iida
    Fumi Gomi
    Junko Morii
    Eriko Kunikane
    Taiji Sakamoto
    Ophthalmology and Therapy, 2023, 12 : 2005 - 2021
  • [43] Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
    Yanagi, Yasuo
    Takahashi, Kanji
    Iida, Tomohiro
    Gomi, Fumi
    Morii, Junko
    Kunikane, Eriko
    Sakamoto, Taiji
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 2005 - 2021
  • [44] Cost-Effectiveness of Ranibizumab Compared with Photodynamic Treatment of Neovascular Age-Related Macular Degeneration
    Javier Hernandez-Pastor, Luis
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    CLINICAL THERAPEUTICS, 2008, 30 (12) : 2436 - 2451
  • [45] Intravitreal bevacizumab for neovascular age-related macular degeneration
    Ladewig, M. S.
    Ziemssen, F.
    Jaissle, G.
    Helb, H. -M.
    Scholl, H. P. N.
    Eter, N.
    Bartz-Schmidt, K. U.
    Holz, F. G.
    OPHTHALMOLOGE, 2006, 103 (06): : 463 - +
  • [46] Effect of intravitreal aflibercept (Eylea®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration
    Gok, Mustafa
    Kapti, Hasan Burhanettin
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (02) : 713 - 719
  • [47] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [48] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [49] Retinal Pigment Epithelial Tear After Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
    Sato, Taku
    Ooto, Sotaro
    Suzuki, Mihoko
    Spaide, Richard F.
    Ophthalmic Surgery Lasers & Imaging Retina, 2015, 46 (01): : 87 - 90
  • [50] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
12345